No phaseRecruiting
Prevail Global Study
A Randomized Controlled Study of the Prevail Drug-Coated Balloon in Subjects With In-stent Restenosis and a Single Arm Prospectively Enrolled Study of the Prevail Drug-Coated Balloon for de Novo Lesions in Small Vessel Disease (Prevail Global).
- Sponsor
- Medtronic Vascular (Industry)
- Enrollment
- 1,205 planned
- Conditions
- Coronary Artery Disease
- Interventions
- Prevail DCB; Agent DCB
- Ages
- adults, older adults
- Registry
- NCT06535854
Full record on ClinicalTrials.gov
From the registry
The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.
Primary outcomes
- ISR Cohort Primary Analysis
- DNSV Cohort Primary Analysis
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered